The researchers showed that when curcumin is intentionally given to bacteria as food and then activated by light, it can trigger deleterious reactions within these microbes, eventually killing them.

It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

The FDA has approved the intravenous antibiotic Emblaveo for adults with complicated intra-abdominal infections who have limited treatment options.

A symptom of COVID is the loss of taste or smell. Tuberculosis has a longer incubation period, and the symptoms have a much ...

NORTH CHICAGO, Ill. - The U.S. Food and Drug Administration (FDA) has approved EMBLAVEO™ (aztreonam and avibactam) for the ...

Schools around the U.S. are closing due to surges of flu and other illnesses which are sickening students and staff. Here's ...